Corporate
Minerva Neurosciences Details Phase 3 Roluperidone Trial at LifeSci KOL Event — First Patient Expected Q2 2026
Feb 3
You're signed outSign in or to get full access.
MN
Minerva Neurosciences (NERV)·Earnings Reports
Q4 2014
View earnings summary and analysis
Q3 2014
View earnings summary and analysis
Q2 2014
View earnings summary and analysis
Research analysts covering Minerva Neurosciences.